MarginProbe uses radio frequency waves to detect microscopic amounts of cancer cells or tissue not visible or left behind in the margin, or outer edge, when a lump is removed from a breast.

In approximately five minutes, within the operating room, surgeons can now have immediate information about the presence of cancer cells on the margins of the tumor.

"This brand new technology could potentially prevent second or third surgeries, allowing the surgeon to get all the cancerous tissue in one surgery. Detecting microscopic cancerous matter before was extremely difficult. This not only makes it easier on the patient, but allows a quicker way to deal with cancerous tissue, when time is of the utmost importance" said Raouf Mikhail, MD, FACS, FRCS.(C), Chief, Department of Surgery, Director, Hurley Comprehensive Breast Cancer Program and Medical Director, Hurley Cancer Center. Dr. Mikhail is Board-Certified in Breast Surgery, General Surgery, and Surgical Oncology.

As the region’s leader in breast health and breast cancer treatment, the Hurley Breast Cancer Program provides the highest level of clinical breast cancer care and compassion for patients and their families.

The Breast Cancer Program at Hurley Medical Center is certified by the National Accreditation Program for Breast Centers (NAPBC), the only accrediting body of the American College of Surgeons’ Commission on Cancer that accredits breast programs.

Hurley is the first medical center in Genesee County to receive this distinction – out of a total of only six medical facilities statewide. A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their battle against breast disease.

Hurley Medical Center is a 443-bed premier public teaching hospital located in the heart of Genesee County, Michigan